Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Metformin and Glimepiride (Low Dosage); Drug: Metformin and Vildagliptin (Low Dosage); Drug: Metformin and Insulin Glargine U100 (Low Dosage); Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage); Drug: Metformin and Glimepiride (Regular Dosage); Drug: Metformin and Vildagliptin (Regular Dosage); Drug: Metformin and Insulin Glargine U100 (Regular Dosage); Drug: Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage) Sponsor: University of Jordan Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Jordan Health | Lantus | Metformin | Middle East Health | Research